Created Date: 10 February 2020
创作日期10 February 2020
Corporate

Carey Olsen advises Bridgepoint on sale of Estera

A cross-jurisdictional Carey Olsen team has advised leading European private equity investor Bridgepoint on the sale of Estera, a global provider of funds, corporate and trust services, to Inflexion-backed Ocorian.

Following the obtaining of the necessary regulatory approvals, the newly-merged Ocorian and Estera will now operate under the Ocorian name from 18 key global jurisdictions, with more than 1,250 professionals serving over 8,000 clients across the corporate service, fund administration and private client sector.

Carey Olsen worked alongside lead counsel Travers Smith, advising Bridgepoint on the Jersey, Bermuda, British Virgin Islands, Cayman Islands and Guernsey legal and regulatory aspects of the transaction.

The global Carey Olsen team was led by corporate partner Guy Coltman, assisted in Jersey by senior associate David Taylor and associate Natasha Lyons. Also advising were partner Mary Ward (Bermuda), partner Tom Carey and associate Colin Calvert (Guernsey), partner Clinton Hempel and counsel Elizabeth Killeen (the British Virgin Islands), partner Anthony McKenzie, counsel Graham Stoute and senior associate Susan McKinstray (the Cayman Islands).

Guy Coltman commented: "Working together as a cross-jurisdictional team from Carey Olsen, utilising specialists in each of our offices and across all time zones, we were delighted to assist Travers Smith and Bridgepoint with this important transaction. Transactions like this, stretching across different jurisdictions and time zones, also provide the opportunity to demonstrate the depth and breadth of our global M&A offering and the seamless global service Carey Olsen can provide to clients."

Bridgepoint's other advisers included Deutsche Bank and ING (M&A), KPMG (financial and tax), Duff and Phelps (regulatory) and BAE (information technology).

Media enquiries

For media enquiries, please contact [email protected]

Subscribe

Sign up here to receive our news and briefings.

Sign up